RadNet Reports Strong Q3 Results and Revises 2025 Guidance Upwards

RadNet, Inc. (NASDAQ: RDNT), a prominent provider of outpatient diagnostic imaging services and digital health solutions, announced impressive financial results for the third quarter of 2025. The company reported record quarterly revenue of $522.9 million, reflecting a 13.4% increase compared to the same period last year. Adjusted EBITDA also surged to $84.9 million, up 15.2% year-over-year, marking a significant margin expansion of 26 basis points.

Dr. Howard Berger, President and CEO of RadNet, highlighted the ongoing growth across both the Imaging Center and Digital Health segments. He stated, "The business continues to demonstrate strong growth and record results... Contributing to these achievements were several factors, including increased procedural volume and ongoing business mix shifts towards advanced imaging."

In the third quarter, RadNet experienced substantial growth in advanced imaging procedural volumes. Aggregate advanced imaging procedural volumes increased by 13.0%, while same-center advanced imaging grew by 9.9% compared to the previous year. This growth has led to an enhanced business mix, with advanced imaging now accounting for 28.2% of all procedures, up from 26.7% in the third quarter of 2024.

Dr. Berger noted, "Given the positive trends we are experiencing in virtually all aspects of the business and the strong financial performance of the third quarter, we are revising upwards certain guidance levels."

In light of the robust performance, RadNet has revised its financial guidance for 2025. The company has increased its revenue and adjusted EBITDA guidance for its Imaging Center segment, with the revised revenue range now set between $1.900 billion and $1.930 billion and adjusted EBITDA between $276 million and $284 million. The Digital Health segment also saw an upward revision in revenue guidance due to strong performance, particularly from iCAD revenue contributions initiated in mid-July.

RadNet's balance sheet remains solid, with a cash balance of $804.7 million at the end of the quarter and a leverage ratio of net debt to adjusted EBITDA of approximately 1.0. This strong liquidity position offers the company the financial flexibility to pursue organic growth and strategic acquisitions in both imaging centers and digital health targets.

Despite facing several unusual or one-time items, such as a $2.6 million non-cash loss from interest rate swaps and $2.1 million in acquisition transaction costs, RadNet's adjusted earnings totaled $15.8 million, leading to an adjusted earnings per share of $0.20.

For the first nine months of 2025, RadNet reported total revenue of $1.492 billion, marking a 10.3% increase over the same period in 2024, with adjusted EBITDA of $212.5 million.

RadNet's management team, including Dr. Howard Berger and Mark Stolper, Executive Vice President and CFO, will host a conference call on November 10, 2025, at 10:30 a.m. Eastern Time to discuss the third quarter results and answer investor questions.

With robust growth in advanced imaging services and a strong financial position, RadNet is poised for continued success in the diagnostic imaging sector. The upward revision of its financial guidance reflects strong operational performance and market demand, positioning the company favorably for the remainder of 2025 and beyond.